The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019
Introduction No survey has evaluated hypertensive heart disease (HHD) burden with statistics from the Risk Factors Study, Injuries, and the Global Burden of Diseases (GBD) 2019. Material and methods The evaluated annual percentage changes (EAPCs) were obtained to assess the trend in prevalence stan...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2023-07-01
|
| Series: | Archives of Medical Science |
| Subjects: | |
| Online Access: | https://www.archivesofmedicalscience.com/The-prevalence-disability-adjusted-life-years-and-mortality-of-hypertensive-heart,169477,0,2.html |
| _version_ | 1797435488831799296 |
|---|---|
| author | Jili Qian Yingqun Chen Donghui Lu Jiner Ma Kuikui Liu |
| author_facet | Jili Qian Yingqun Chen Donghui Lu Jiner Ma Kuikui Liu |
| author_sort | Jili Qian |
| collection | DOAJ |
| description | Introduction
No survey has evaluated hypertensive heart disease (HHD) burden with statistics from the Risk Factors Study, Injuries, and the Global Burden of Diseases (GBD) 2019.
Material and methods
The evaluated annual percentage changes (EAPCs) were obtained to assess the trend in prevalence standardized by age, mortality rates standardized by age, and DALYs standardized by age between 1990 and 2019. We also evaluated the contribution of risk factors to HHD-associated DALYs and mortality.
Results
Between 1990 and 2019, the worldwide prevalence rate standardized by age increased (EAPC = 0.17; 95% confidence interval (CI) 0.15 to 0.18), but the death rate standardized by age (EAPC = –0.74; 95% CI: –0.91 to –0.57) and DALYs standardized by age rate decreased (EAPC = –1.02; 95% CI: –1.18 to –0.86). The prevalence rate of HHD standardized by age increased the most in the high-middle areas of SDI (EAPC = 0.43). The biggest increases in the prevalence rate standardized by age were in Andean Latin America (EAPC = 0.43), Western Sub-Saharan Africa (EAPC = 0.30), and the Middle East and North Africa (EAPC = 0.24). The largest decrease in mortality that could be attributed to rate and DALYs in both sexes between 1990 and 2019 was consistent with a high BMI.
Conclusions
The worldwide prevalence rate standardized by age increased during 1990-2019, especially in Andean Latin America, North Africa, the Middle East, and Western Sub-Saharan Africa. Future HHD prevention tactics should be focused on males, high-risk areas, and control of high BMI. |
| first_indexed | 2024-03-09T10:48:49Z |
| format | Article |
| id | doaj.art-e00f5723a7ee4046a491f89e81f4961e |
| institution | Directory Open Access Journal |
| issn | 1734-1922 1896-9151 |
| language | English |
| last_indexed | 2024-03-09T10:48:49Z |
| publishDate | 2023-07-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Archives of Medical Science |
| spelling | doaj.art-e00f5723a7ee4046a491f89e81f4961e2023-12-01T09:49:08ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512023-07-011951186120010.5114/aoms/169477169477The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019Jili Qian0Yingqun Chen1Donghui Lu2Jiner Ma3Kuikui Liu4Department of Cardiovascular Medicine, Yuyao People’s Hospital, Ningbo, Zhejiang, ChinaDepartment of General Practice, Yuyao People’s Hospital, Ningbo, Zhejiang, ChinaEmergency Trauma Department, Yuyao People’s Hospital, Ningbo, Zhejiang, ChinaDepartment of Geriatrics, Yuyao People’s Hospital, Ningbo, Zhejiang, ChinaDepartment of Geriatrics, Yuyao People’s Hospital, Ningbo, Zhejiang, ChinaIntroduction No survey has evaluated hypertensive heart disease (HHD) burden with statistics from the Risk Factors Study, Injuries, and the Global Burden of Diseases (GBD) 2019. Material and methods The evaluated annual percentage changes (EAPCs) were obtained to assess the trend in prevalence standardized by age, mortality rates standardized by age, and DALYs standardized by age between 1990 and 2019. We also evaluated the contribution of risk factors to HHD-associated DALYs and mortality. Results Between 1990 and 2019, the worldwide prevalence rate standardized by age increased (EAPC = 0.17; 95% confidence interval (CI) 0.15 to 0.18), but the death rate standardized by age (EAPC = –0.74; 95% CI: –0.91 to –0.57) and DALYs standardized by age rate decreased (EAPC = –1.02; 95% CI: –1.18 to –0.86). The prevalence rate of HHD standardized by age increased the most in the high-middle areas of SDI (EAPC = 0.43). The biggest increases in the prevalence rate standardized by age were in Andean Latin America (EAPC = 0.43), Western Sub-Saharan Africa (EAPC = 0.30), and the Middle East and North Africa (EAPC = 0.24). The largest decrease in mortality that could be attributed to rate and DALYs in both sexes between 1990 and 2019 was consistent with a high BMI. Conclusions The worldwide prevalence rate standardized by age increased during 1990-2019, especially in Andean Latin America, North Africa, the Middle East, and Western Sub-Saharan Africa. Future HHD prevention tactics should be focused on males, high-risk areas, and control of high BMI.https://www.archivesofmedicalscience.com/The-prevalence-disability-adjusted-life-years-and-mortality-of-hypertensive-heart,169477,0,2.htmlglobal burden of disease studyhypertensive heart diseaseprevalencedalydeath |
| spellingShingle | Jili Qian Yingqun Chen Donghui Lu Jiner Ma Kuikui Liu The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019 Archives of Medical Science global burden of disease study hypertensive heart disease prevalence daly death |
| title | The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019 |
| title_full | The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019 |
| title_fullStr | The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019 |
| title_full_unstemmed | The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019 |
| title_short | The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019 |
| title_sort | prevalence disability adjusted life years and mortality of hypertensive heart disease and its attributable risk factors results from the global burden disease study 2019 |
| topic | global burden of disease study hypertensive heart disease prevalence daly death |
| url | https://www.archivesofmedicalscience.com/The-prevalence-disability-adjusted-life-years-and-mortality-of-hypertensive-heart,169477,0,2.html |
| work_keys_str_mv | AT jiliqian theprevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT yingqunchen theprevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT donghuilu theprevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT jinerma theprevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT kuikuiliu theprevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT jiliqian prevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT yingqunchen prevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT donghuilu prevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT jinerma prevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 AT kuikuiliu prevalencedisabilityadjustedlifeyearsandmortalityofhypertensiveheartdiseaseanditsattributableriskfactorsresultsfromtheglobalburdendiseasestudy2019 |